Heart Test Valuation
| HSCS Stock | USD 5.11 0.18 3.40% |
At this time, the firm appears to be overvalued. Heart Test Laboratories retains a regular Real Value of $4.25 per share. The prevalent price of the firm is $5.11. Our model calculates the value of Heart Test Laboratories from evaluating the firm fundamentals such as return on asset of -0.53, and Return On Equity of -1.53 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Heart Test's valuation include:
Price Book 0.8125 | Enterprise Value -2.5 M | Enterprise Value Ebitda (0.17) | Price Sales 377.1554 | Enterprise Value Revenue 53.6642 |
Overvalued
Today
Please note that Heart Test's price fluctuation is very risky at this time. Calculation of the real value of Heart Test Laboratories is based on 3 months time horizon. Increasing Heart Test's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Heart stock is determined by what a typical buyer is willing to pay for full or partial control of Heart Test Laboratories. Since Heart Test is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heart Stock. However, Heart Test's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.11 | Real 4.25 | Target 3.6 | Hype 5.02 | Naive 5.38 |
The intrinsic value of Heart Test's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heart Test's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heart Test Laboratories helps investors to forecast how Heart stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heart Test more accurately as focusing exclusively on Heart Test's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Heart Test's intrinsic value based on its ongoing forecasts of Heart Test's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Heart Test's closest peers.
Heart Test Investments |
|
Heart Valuation Trend
Knowing Heart Test's actual value is paramount for traders to make sound investment determinations. Heart Test's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Heart Test's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Heart Test's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Heart Market Cap
Heart Test Laboratories is rated # 2 in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 6.94 Million. Heart Test totals roughly 3.47 Million in market capitalization claiming about 50% of equities under Health Care industry.Heart Test Total Value Analysis
Heart Test Laboratories is currently forecasted to have valuation of (2.55 M) with market capitalization of 3.47 M, debt of 1.57 M, and cash on hands of 4.27 M. The negative valuation of Heart Test may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Heart Test fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
| (2.55 M) | 3.47 M | 1.57 M | 4.27 M |
Heart Test Investor Information
About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Heart Test Laboratories recorded a loss per share of 35.0. The entity had not issued any dividends in recent years. The firm had 1:100 split on the 17th of May 2024. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To learn more about Heart Test Laboratories call Andrew Simpson at 682 237 7781 or check out https://heartsciences.com.Heart Test Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Heart Test has an asset utilization ratio of 0.16 percent. This implies that the Company is making $0.001567 for each dollar of assets. An increasing asset utilization means that Heart Test Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Heart Test Ownership Allocation
Heart Test retains 16.0 (percent) of its outstanding shares held by insiders and 2.372 (percent) owned by outside corporations.Heart Test Profitability Analysis
The company reported the previous year's revenue of 5.15 K. Net Loss for the year was (6.35 M) with profit before overhead, payroll, taxes, and interest of 2.35 K.About Heart Test Valuation
The stock valuation mechanism determines the current worth of Heart Test Laboratories on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Heart Test Laboratories. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Heart Test Laboratories based exclusively on its fundamental and basic technical indicators. By analyzing Heart Test's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Heart Test's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heart Test. We calculate exposure to Heart Test's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Heart Test's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 K | 2 K | |
| Pretax Profit Margin | -1.4 K | -1.3 K | |
| Operating Profit Margin | -1.4 K | -1.3 K | |
| Net Loss | -109.6 K | -104.1 K | |
| Gross Profit Margin | 0.41 | 0.35 |
8 Steps to conduct Heart Test's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Heart Test's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Heart Test's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Heart Test's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Heart Test's revenue streams: Identify Heart Test's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Heart Test's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Heart Test's growth potential: Evaluate Heart Test's management, business model, and growth potential.
- Determine Heart Test's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Heart Test's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Heart Test Growth Indicators
Investing in growth stocks can be very risky. If the company such as Heart Test does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 8 M |
Heart Test Current Valuation Indicators
Valuation refers to the process of determining the present value of Heart Test Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Heart we look at many different elements of the entity such as Heart's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Heart Test's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Heart Test's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Heart Test, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Heart Test's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Heart Test's worth.Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.